GRAIL Completes Enrollment of More Than 35,000 Participants in the PATHFINDER 2 Study; Results From the First 25,000 Participants Expected in the Second Half of 2025 GRAIL Completes Final Study Visits ...
The following slide deck was published by GRAIL, Inc. in conjunction with this event.
Results From the First 25,000 Participants Expected in the Second Half of 2025 GRAIL Completes Final Study Visits for the NHS-Galleri Trial; Final Results Expected in 2026 PATHFINDER 2 is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback